Real world analysis of ribociclib treatment in HR(+) HER2(-) metastatic breast cancer in a Taiwanese cohort

First Author / 第一作者

Jiun-I Lai

Institution / 單位

Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan

Audio / 音訊檔

Author Group / 作者群

Jiun-I Lai, MD. PhD1,2. Chi-Cheng Huang, MD. PhD2,3 . Yi-Fang Tsai, MD. PhD2,3. . Chun-Yu Liu, MD. PhD1,2. Ling-Ming Tseng, MD. PhD2,3. Ta-Chung Chao, MD. PhD1,2

Author Group Institution/ 作者群單位

1. Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan. 2. Comprehensive Breast Center, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan. 3. Division of General Surgery, Department of Surgery, Taipei Veterans General Hospital

Category / 主題分類

Clinical Research

Keyword / 關鍵字

ribociclib, CDK4/6

Back to list